These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 24268959)

  • 21. [Sexual function rehabilitation of men with pituitary tumors].
    Rozhivanov RV; Kurbatov DG
    Urologiia; 2010; (4):48, 50-3. PubMed ID: 20973135
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Testosterone replacement in men.
    Beg S; Al-Khoury L; Cunningham GR
    Curr Opin Endocrinol Diabetes Obes; 2008 Aug; 15(4):364-70. PubMed ID: 18594278
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Testosterone metabolism and replacement therapy in patients with end-stage renal disease.
    Johansen KL
    Semin Dial; 2004; 17(3):202-8. PubMed ID: 15144546
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A phase IV prospective evaluation of the safety and efficacy of extended release testosterone pellets for the treatment of male hypogonadism.
    Kaminetsky JC; Moclair B; Hemani M; Sand M
    J Sex Med; 2011 Apr; 8(4):1186-96. PubMed ID: 21269402
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Androgen replacement therapy for hypogonadal men].
    Cui YG; Jia Y; Di FS; Wang XH
    Zhonghua Nan Ke Xue; 2003 Jun; 9(3):210-3. PubMed ID: 12861839
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Case report: treatment of androgen deficiency in the aging male.
    Hernandez A; Baum N
    Postgrad Med; 2008 Nov; 120(4):73-7. PubMed ID: 19020368
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Late-life onset hypogonadism: a review.
    Bassil N; Morley JE
    Clin Geriatr Med; 2010 May; 26(2):197-222. PubMed ID: 20497841
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of testosterone replacement therapy on nocturia and quality of life in men with hypogonadism: a subanalysis of a previous prospective randomized controlled study in Japan.
    Shigehara K; Konaka H; Koh E; Izumi K; Kitagawa Y; Mizokami A; Nakashima T; Shimamura M; Iwamoto T; Namiki M
    Aging Male; 2015; 18(3):169-74. PubMed ID: 26075538
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The long-term efficacy and safety of a testosterone mucoadhesive buccal tablet in testosterone-deficient men.
    Dinsmore WW; Wyllie MG
    BJU Int; 2012 Jul; 110(2):162-9. PubMed ID: 22288877
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Testosterone replacement therapy for treatment refractory cluster headache.
    Stillman MJ
    Headache; 2006 Jun; 46(6):925-33. PubMed ID: 16732838
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Treatment of androgen disorder of aging male (ADAM)].
    Rhoden EL; Schiavini JL; Claro JA
    Int Braz J Urol; 2006; 32 Suppl 1():20-5. PubMed ID: 23631037
    [No Abstract]   [Full Text] [Related]  

  • 32. Testosterone replacement therapy in hypogonadal men: assessing benefits, risks, and best practices.
    Miner M; Canty DJ; Shabsigh R
    Postgrad Med; 2008 Sep; 120(3):130-53. PubMed ID: 18824832
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Testosterone: myocardial infarction and stroke.
    Prescrire Int; 2014 Oct; 23(153):240-1. PubMed ID: 25964971
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Estradiol levels in men with congenital hypogonadotropic hypogonadism and the effects of different modalities of hormonal treatment.
    Trabado S; Maione L; Salenave S; Baron S; Galland F; Bry-Gauillard H; Guiochon-Mantel A; Chanson P; Pitteloud N; Sinisi AA; Brailly-Tabard S; Young J
    Fertil Steril; 2011 Jun; 95(7):2324-9, 2329.e1-3. PubMed ID: 21536274
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Testosterone undecanoate in the treatment of male hypogonadism.
    Edelstein D; Basaria S
    Expert Opin Pharmacother; 2010 Aug; 11(12):2095-106. PubMed ID: 20642374
    [TBL] [Abstract][Full Text] [Related]  

  • 36. MYTHS AND CONTROVERSIES IN HYPOGONADISM TREATMENT OF AGING MALES.
    Ungureanu MC; Costache II; Preda C; Mogoş V; Vulpoi C; Leuştean L
    Rev Med Chir Soc Med Nat Iasi; 2015; 119(2):325-33. PubMed ID: 26204632
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Testosterone therapy improves the clinical response to conventional treatment for male patients with metabolic syndrome associated to late onset hypogonadism.
    La Vignera S; Calogero AE; D'Agata R; Di Mauro M; Tumino S; Condorelli R; Lanzafame F; Finocchiaro C; Giammusso B; Vicari E
    Minerva Endocrinol; 2008 Sep; 33(3):159-67. PubMed ID: 18846023
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical use of androgens.
    Snyder PJ
    Annu Rev Med; 1984; 35():207-17. PubMed ID: 6372655
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antimüllerian hormone levels decrease in female-to-male transsexuals using testosterone as cross-sex therapy.
    Caanen MR; Soleman RS; Kuijper EA; Kreukels BP; De Roo C; Tilleman K; De Sutter P; van Trotsenburg MA; Broekmans FJ; Lambalk CB
    Fertil Steril; 2015 May; 103(5):1340-5. PubMed ID: 25772768
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of androgen replacement therapy on atherosclerotic risk markers in young-to-middle-aged men with idiopathic hypogonadotropic hypogonadism.
    Doğan BA; Karakılıç E; Tuna MM; Arduç A; Berker D; Güler S
    Clin Endocrinol (Oxf); 2015 Mar; 82(3):422-8. PubMed ID: 25280063
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.